This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various biologically active molecules. Its structure, featuring both a tert-butoxycarbonyl (Boc) protecting group and a carboxylic acid moiety, makes it valuable for constructing complex drug candidates. It is often employed in the development of compounds targeting central nervous system disorders, as the bipiperidine scaffold can enhance binding affinity to specific receptors. Additionally, the Boc group allows for selective deprotection during multi-step synthetic processes, enabling precise modifications to the molecule. Its application extends to the creation of peptide mimetics and small-molecule inhibitors, particularly in medicinal chemistry research focused on optimizing drug potency and selectivity.